Signify Bio (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- June 05, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $15,000,000
Company Info
- Traction
- Oversubscribed $15 million financing round led by Actium Group with participation from notable investors.
- Organizations Involved
- UT Southwestern Medical Center, Actium Group, Gates Foundation, Danaher Corporation, Eli Lilly and Company, American Cancer Society
- Founders
- RA Session II, Daniel J. Siegwart
- Company Description
- Signify Bio is a Dallas-based biotech company that harnesses the human body for the production of in situ protein therapeutics. The company offers modular platforms to engineer personalized protein therapeutics directly within the body, addressing challenges in drug production, delivery, and efficacy.
- Market
- Protein therapeutics
- Location
- Dallas, Texas, USA
- Coinvestors
- Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, BrightEdge